Craft

Yourgene Health

Stock Price

£0

2023-09-08

Market Capitalization

£16.4 M

2023-09-08

Revenue

£37.6 M

FY, 2022

Yourgene Health Summary

Company Summary

Overview
Yourgene Health (formerly known as Premaitha Health) is an integrated technologies and services company specializing in genomic medicine. It primarily develops, manufactures, and commercializes molecular diagnostic solutions for reproductive health, precision medicine, and infectious diseases. Its products include non-invasive prenatal tests (NIPT) for Down’s Syndrome and other genetic disorders, Cystic Fibrosis screening tests, invasive rapid aneuploidy tests, and DPYD genotyping.
Type
Public
Status
Active
Founded
2013
HQ
Manchester, GB | view all locations
Website
https://yourgenehealth.com
Cybersecurity rating
Sectors

Key People

Operating MetricsView all

Samples Tested

800K

Apr, 2023

Research Partners

100

Apr, 2023

Clinical Partners

250

Apr, 2023

LocationsView all

7 locations detected

  • Manchester, England HQ

    United Kingdom

    Skelton House, Manchester Science Park, Lloyd St N

  • Miami Beach, FL

    United States

    1680 Michigan Ave 700 232

  • Port Coquitlam, BC

    Canada

    Mary Hill Business Park, 1515 Broadway St Unit 702

  • Paris, IDF

    France

    65 Av. Kléber

  • Düsseldorf, NRW

    Germany

    Speditionstraße 15A

  • Singapore

    Singapore

    3 Fusionopolis Pl, #5 54

and 1 others

Yourgene Health Financials

Summary Financials

Revenue (FY, 2022)
£37.6M
Gross profit (FY, 2022)
£21.4M
Net income (FY, 2022)
(£1.9M)
Cash (FY, 2022)
£8.4M
EBIT (FY, 2022)
(£2.5M)
Enterprise value
$27.1M

Footer menu